Related Experiment Video

Updated: Mar 19, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K

Novel targets for ATM-deficient malignancies

Johannes Winkler1, Kay Hofmann1, Shuhua Chen1

  • 1Institute for Genetics; University of Cologne; Cologne, Germany.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Targeting cancer cells with ATM deficiency offers a novel approach to treatment. By inhibiting cooperating pathways, therapies can specifically target tumors while sparing healthy cells, improving efficacy and reducing side effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Conventional cancer therapies (chemo- and radiotherapy) lack specificity, causing severe side effects.
  • ATM protein is crucial for DNA damage response; its deficiency is linked to cancer development.
  • ATM-deficient tumors rely on cooperative pathways for survival, presenting a therapeutic vulnerability.

Purpose of the Study:

  • To review potential drug targets for ATM-deficient malignancies.
  • To explore the mechanisms of targeted therapies for these cancers.

Main Methods:

  • Literature review of ATM's role in DNA damage response.
  • Analysis of cooperative pathways in ATM-deficient tumors.
  • Identification and review of druggable targets and therapeutic mechanisms.

Main Results:

  • ATM deficiency creates dependencies on specific cellular pathways for tumor cell survival.
  • Inhibiting these cooperative pathways offers a strategy for targeted cancer therapy.
  • Several druggable protein targets have been identified for ATM-deficient malignancies.

Conclusions:

  • Targeted inhibition of cooperative pathways is a promising strategy for treating ATM-deficient cancers.
  • This approach aims for higher efficacy and tumor specificity compared to conventional treatments.
  • Further research into these targets could lead to novel, less toxic cancer therapies.
Keywords:
ATMDNA damage responseHomologous recombinationpersonalized therapysynthetic lethality

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K